tykhr
sign in
free sign up
Clarus Therapeutics Holdings Inc
Drug Manufacturers-General
Healthcare
CRXT
9.15 M shares
NASDAQ US
traded
22 Apr 2022
listed
yes
open
2.06
52 week high
9.63
high
2.18
52 week low
1.34
low
1.78
growth
-77.19 %
previous Close
2.31
P/E ratio
market cap
28.71 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
0.00 %
eps
5.74 %
eps surprise
0.00 %
net profit margin
0.00 %
286.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top